Pharma Groups Hope for Diet Drugs Binge CNBC.com Meanwhile, Wyeth, now part of Pfizer, is still fighting claims of heart valve defects and other problems linked to Fen-Phen, a combination of diet drugs withdrawn in 1997 for which it earmarked reserves of $21 billion to cover settlements. Regulators ... See all stories on this topic »
No comments:
Post a Comment